Financials
- Market Capitalization 279.59 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.14
市销率
26.03
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3295 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.75 USD | -0.53% | +0.81% | -1.83% | -56.40% | 286.11 M USD | ||
| 3311 | ABEO Abeona Therapeutics Inc. - Common Stock | 4.90 USD | -0.81% | -5.04% | -9.43% | -8.07% | 280.20 M USD | ||
| 3314 | PALI Palisade Bio, Inc. - Common Stock | 1.59 USD | +3.25% | +5.30% | -22.44% | -6.47% | 277.09 M USD | ||
| 3319 | NAUT Nautilus Biotechnology, Inc. - Common Stock | 2.17 USD | -3.56% | +16.04% | +114.85% | +138.46% | 276.14 M USD |